NEW YORK (GenomeWeb) – Invitae said today that it has acquired health software developer Ommdom and its genomic management tool CancerGene Connect, an end-to-end platform for collecting and managing genetic family histories.
Under the terms of the agreement, Invitae acquired all Ommdom's outstanding capital stock in exchange for approximately $6 million in Invitae common stock.
According to Invitae, the acquisition expands its existing suite of technologies that help patients and clinicians use genetic information as part of mainstream medical care.